AB SCIENCE Investor Relations Material
Latest events
Status Update
AB SCIENCE
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AB SCIENCE
Access all reports
AB Science is a biotechnology company specializing in the research, development, and commercialization of targeted therapies for serious diseases. The company focuses on small molecule drugs designed to address conditions in oncology, neurodegenerative disorders, and inflammatory diseases. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
)
)
)